Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
1,000 NPA accounts under scanner in ICICI Bank probe

2018-07-12 livemint
Mumbai: ICICI Bank Ltd is preparing to submit details of at least 1,000 loan accounts that turned sour since April 2010 to an independent panel, as part of a board-instituted probe into alleged wrongdoings by the lender’s top executives, including its off-duty CEO Chanda Kochhar, two people aware of the development said.
ICICIBANK ABGSHIP 532682 532670 GAMMONIND BHUSANSTL 532174 IBN 509550 RENUKA 500055

0
Shree Renuka Sugars Limited - Updates

2018-07-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532670 RENUKA

0
Shree Renuka Sugars Limited - Updates

2018-07-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532670 RENUKA

0
Shree Renuka Sugars Limited - Updates

2018-07-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532670 RENUKA

5
Closing Bell: Sensex rises 114 pts, Nifty ends tad below 10,700; pharma, auto, IT outshine

2018-07-03 moneycontrol
Global Update: Asian stocks closed mixed as investors remained cautious ahead of a July 6 deadline when the US is set to impose tariffs on $34 billion worth of goods from China. Beijing is then expected to respond with charges of its own on US goods, reports CNBC.
500325 UBL TTQQY 532478 TATACHEM CADILAHC 532321 BJJQY 500570 500770 RLNIY 513010 AXB MRZUY 532500 AXBA BAJAJFINSV BAJFINANCE 532670 TATASTEEL TATLY MARUTI 500180 KOTAKBANK 507458 523204 SSWL 513262 533271 RELIANCE IDBI 532737 ASHOKA 532978 RENUKA 532215 ABAN 500470 AXISBANK RIGD TATASPONGE HDFCBANK NIHARINF TATAMOTORS 500034 500116 KMBKY TATAMETALI IBN UBHOLDINGS 513434 532967 KIRIINDUS UNBWY CDLYY AXBKY ICICIBANK TTST EMKAY HDB 532174 531083 500247 TTM

0
Shree Renuka Sugars Limited - Post Offer Public Announcement

2018-07-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532670 RENUKA

1
Market Live: Sensex gains strength, Nifty reclaims 10,700; Nikkei, Shanghai recover from day#39;s low

2018-07-03 moneycontrol
Market Expert: Dhananjay Sinha, Head of Research, Economist and Strategist, Emkay Global Financial Services told CNBC-TV18 that the announcement of minimum support price (MSP) is critical even if it’s coming with a delay.
GRASIM 500325 UBL MS.PRE MS.PRF MS.PRG MS.PRA ASIANPAINT 532478 534816 MS RLNIY ASHOKLEY GRSJY TATAPOWER YYBKY AKLD MS.PRI 532670 MS.PRK 500180 526797 500300 507458 AKLS BHRYY 500820 RELIANCE IDBI 532737 RENUKA RIGD GREENPLY INFRATEL HDFCBANK 500477 YESBANK 500116 IBN UBHOLDINGS 532648 UNBWY GRSXY ICICIBANK EMKAY HDB 532174 TPCL 500400

0
Shree Renuka Sugars Limited - Resignation

2018-07-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532670 RENUKA

0
Shree Renuka Sugars Limited - Resignation

2018-06-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532670 RENUKA

0
Shree Renuka Sugars Limited - Resignation

2018-06-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532670 RENUKA

0
Shree Renuka Sugars Limited - Updates

2018-06-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532670 RENUKA

0
Wilmar Sugar buys 19.77% additional stake in Shree Renuka Sugars via open offer

2018-06-28 moneycontrol
Singapore-based Wilmar Sugar Holdings (WSH) has acquired an additional 19.77 percent stake in Shree Renuka Sugars through an open offer which was launched a few months back. Mumbai-based Shree Renuka Sugars informed about this development in a regulatory filing today.
532670 RENUKA

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...